CUSIP: 37185X106
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / CL A COM
-
Total 13F shares
-
23,091,291
-
Share change
-
-3,059,692
-
Total reported value
-
$12,560,844
-
Price per share
-
$0.54
-
Number of holders
-
45
-
Value change
-
-$1,831,276
-
Number of buys
-
11
-
Number of sells
-
34
Quarterly Holders Quick Answers
What is CUSIP 37185X106?
CUSIP 37185X106 identifies GENN - GENESIS HEALTHCARE INC - CL A COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 37185X106:
Institutional Holders of GENESIS HEALTHCARE INC - CL A COM (GENN) as of Q3 2020
As of 30 Sep 2020,
GENESIS HEALTHCARE INC - CL A COM (GENN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,091,291 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, First Washington CORP, V3 Capital Management, L.P., Chevy Chase Trust Holdings, Inc., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.